TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Aera Therapeutics Stock

Aera Therapeutics Stock

aeratx.comHealthcareFounded: 2021

Aera Therapeutics is a biotechnology and research company that develops new ways to deliver genetic medicine into cells. Through Aera’s proprietary protein nanoparticle (PNP) delivery platform, the Boston-based company is working to improve the treatment of human disease. The PNP platform is applied across a range of therapeutic applications.

Buy or sell Aera Therapeutics stockLearn more about Aera Therapeutics IPO
Register for Details

For more details on financing and valuation for Aera Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Aera Therapeutics.

Register Today

Aera Therapeutics investors also invested in these private companies

Lux Capital
GV
Arch Venture Partners

Team

Management Team

Akin Akinc Ph.D
Chief Executive Officer
Feng Zhang Ph.D
Founder

Other companies like Aera Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

THE WASHINGTON POST 02/23/2023
A Refreshing Gamble on Crispr Delivery
A privately held biotech company called Aera Therapeutics came out of stealth recently to debut a type of protein nanoparticle that it believes can be used to ferry all sorts of genetic medicines around the body.
FIERCE BIOTECH 02/16/2023
On hunt for better gene med delivery, Aera exits stealth with $193M and Alnylam vet at helm
Led by a 20-year Alnylam veteran, Aera Therapeutics has emerged with $193 million in hand and hopes of unlocking genetic medicine’s fullest potential.
GEN 02/16/2023
Feng Zhang’s Delivery Platform Launched by Aera Therapeutics
Feng Zhang, PhD, institute member at the Broad Institute and HHMI Investigator, has an uncanny ability to be in the middle of (or on the leading edge of) the hottest topics in biological research.

Trending Companies

Frequently Asked Questions